Virion\Serion is proud to introduce new high-quality antigens designed to enhance the accuracy of serological diagnostics for two globally significant mosquito-borne viruses:
- Dengue Virus Type 2 Envelope Protein E (BA114R01)
- West Nile Virus Envelope Protein E (BA141R01)
- West Nile Virus 6His-4ED3 Antigen (BA141VSR14)
With Dengue Virus infections now exceeding 400 million annually and West Nile Virus resurging across multiple continents, the need for reliable, high-performance diagnostic tools is greater than ever. Factors like urbanization, climate change and global travel are accelerating the spread and frequency of outbreaks.
Accurate and timely detection through ELISA and CLIA serological testing is vital for patient care, surveillance, and outbreak response. These newly released SERION antigens offer exceptional quality and consistency, supporting the development of next-generation diagnostics that can meet today's public health challenges.
Choose SERION antigens. Strengthen your diagnostics. Protect global health.